![3-{1-azatricyclo[6.3.1.0',¹²]dodeca-2,4,6,8(12)-tetraen-3-yl}-4-(1H-indol-3-yl)pyrrolidine-2,5-dione](https://static.cymitquimica.com/products/3D/img/PZB98650.png "Haga clic para ampliar")
3-{1-azatricyclo[6.3.1.0',¹²]dodeca-2,4,6,8(12)-tetraen-3-yl}-4-(1H-indol-3-yl)pyrrolidine-2,5-dione
CAS: 1239986-50-5
Ref. 3D-PZB98650
| 25mg | A consultar | ||
| 50mg | A consultar | ||
| 100mg | A consultar | ||
| 250mg | A consultar | ||
| 500mg | A consultar |
Información del producto
Tivantinib is a monoclonal antibody that targets the MET receptor tyrosine kinase and inhibits its activity. MET is involved in cell proliferation, migration, and adhesion. Tivantinib has been shown to inhibit the growth of metastatic colorectal cancer cells in mice with body masses below 40 g. Tivantinib also has anti-angiogenic properties that may be due to its inhibition of epidermal growth factor (EGF). Tivantinib binds to actin filaments and inhibits the formation of c-met, leading to an increase in the concentration-time curve for tivantinib.
Propiedades químicas
Consulta técnica sobre: 3D-PZB98650 3-{1-azatricyclo[6.3.1.0',¹²]dodeca-2,4,6,8(12)-tetraen-3-yl}-4-(1H-indol-3-yl)pyrrolidine-2,5-dione
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
